576.80
+0.4(+0.07%)
Currency In GBp
Address
Maurice Wilkes Building
Cambridge, CB4 0DS
United Kingdom of Great Britain and Northern Ireland
Phone
44 1223 394 100
Website
Sector
Technology
Industry
Software - Infrastructure
Employees
2300
First IPO Date
April 30, 2021
Name | Title | Pay | Year Born |
Ms. Jill Popelka | Chief Executive Officer, Chief Operating Officer & Director | 0 | N/A |
Ms. Catherine A. Graham | Chief Financial Officer & Executive Director | 769,100 | 1960 |
Ms. Poppy Clare Veronica Gustafsson O.B.E. | Executive Director | 1.66M | 1982 |
Mr. John Allen | Vice President of Cyber Risk & Compliance | 0 | N/A |
Mr. Jack Stockdale O.B.E. | Co-Founder & Chief Technology Officer | 0 | N/A |
Mr. David Smith | Chief People Officer | 0 | 1964 |
Mr. Luk Janssens | Head of Investor Relations | 0 | N/A |
Mr. Chris Kozup | Chief Marketing Officer | 0 | N/A |
Mr. James Alan Sporle | General Counsel & Company Secretary | 0 | 1976 |
Ms. Nicole Eagan | Chief Strategy Officer & AI Officer | 0 | 1965 |
Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Canada, Europe, and internationally. Its products include Enterprise Immune System to discover unpredictable cyber-threats; Industrial Immune System to detect novel threats and vulnerabilities, as well as safeguard the integrity and resilience of industrial technologies; and Cyber AI Analyst, an AI investigation technology, which automatically triages, interprets, and reports scope of security incidents. The company also provides Darktrace Antigena, an autonomous response technology for the enterprise with various security products that delivers proactive cyber defense to digital infrastructure. It serves critical national infrastructure organizations, financial services companies, technology and healthcare providers, media corporations, and educational institutions. The company was founded in 2013 and is headquartered in Cambridge, the United Kingdom.